Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WI › Kenosha › NPI 1225156888
Physician

Aurora Health Care Southern Lakes, INC.

Aurora Health Care Southern Lakes, INC. was paid $19.94M by Medicaid between Jan 2018 and Dec 2024, across 322 billing codes. Its largest line is 99283, emergency room visit (moderate) — 11% of everything it billed.

33Billing provider infoAURORA HEALTH CARE SOUTHERN LAKES, INC.
KENOSHA, WI 53142
33aNPI1225156888assigned 03/26/2007
28Total paid$19.94M
24GClaims856,891
24DCodes billed322
24AFirst – last monthJan 2018 – Dec 2024

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official RICHARDSON, KARA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201885,772$1.99M
201988,641$2.04M
202079,295$1.94M
2021108,013$2.40M
2022144,276$3.28M
2023194,509$4.26M
2024incomplete156,385$4.03M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 11% 34,103 30,711 $2.12M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 8.2% 45,831 15,853 $1.63M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 8.0% 28,158 24,959 $1.59M
96361 Intravenous infusion, hydration; each additional hour 7.3% 11,658 9,250 $1.46M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.3% 14,857 13,085 $855K
80053 Comprehensive metabolic panel 3.6% 38,296 31,473 $718K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 2.6% 2,693 2,498 $509K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.4% 7,200 6,552 $469K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.3% 6,088 5,582 $458K
70450 Computed tomography, head or brain; without contrast material 2.1% 5,887 5,374 $418K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 2.0% 9,949 9,165 $407K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 2.0% 21,904 8,740 $400K
310 more codes
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 2.0% 4,173 $390K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.7% 3,639 $344K
45380 Colonoscopy, flexible; with biopsy, single or multiple 1.4% 1,501 $272K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.3% 42,009 $267K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.2% 3,473 $244K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.2% 4,278 $243K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 1.2% 1,978 $239K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.1% 7,341 $226K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.1% 3,086 $218K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 1.0% 924 $206K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 1.0% 6,921 $206K
97161 <1% 4,839 $198K
71046 Radiologic examination, chest; 2 views <1% 10,770 $174K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 3,690 $165K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,388 $149K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 3,448 $146K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,401 $143K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 4,113 $142K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 4,583 $138K
71275 Computed tomographic angiography, chest, with contrast material <1% 1,403 $132K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 1,406 $129K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,646 $126K
76830 Ultrasound, transvaginal <1% 3,875 $123K
81025 <1% 12,562 $122K
84484 <1% 11,939 $118K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 2,512 $114K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 2,515 $110K
97597 <1% 2,626 $106K
97162 <1% 3,058 $103K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 359 $102K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 1,752 $102K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 1,777 $99K
82077 <1% 3,565 $87K
93975 <1% 2,170 $86K
87086 Culture, bacterial; quantitative colony count, urine <1% 7,794 $86K
80048 Basic metabolic panel (calcium, ionized) <1% 4,397 $83K
82962 <1% 10,107 $83K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 712 $81K
70551 Magnetic resonance imaging, brain; without contrast material <1% 1,052 $81K
83880 <1% 2,797 $80K
93017 <1% 2,517 $80K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 2,905 $79K
83690 <1% 13,117 $76K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 1,101 $73K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 964 $64K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,760 $63K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,760 $61K
G0378 Hospital observation service, per hour <1% 2,645 $60K
0240U <1% 1,619 $60K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,271 $58K
81001 <1% 15,467 $58K
83735 <1% 10,842 $54K
74018 <1% 3,502 $53K
84145 <1% 2,946 $52K
77067 Screening mammography, bilateral, including computer-aided detection <1% 2,200 $52K
93971 <1% 2,065 $50K
84702 <1% 2,544 $49K
93356 <1% 566 $48K
76801 <1% 2,411 $46K
71250 <1% 1,684 $44K
97165 <1% 1,115 $40K
86850 <1% 1,996 $38K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 663 $36K
72125 Computed tomography, cervical spine; without contrast material <1% 1,388 $35K
86900 <1% 2,547 $35K
83605 <1% 3,826 $32K
72141 <1% 513 $31K
76536 <1% 958 $31K
73630 <1% 3,190 $31K
58661 <1% 30 $31K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 21,704 $31K
87081 <1% 738 $30K
73610 <1% 2,370 $30K
70496 <1% 255 $29K
70498 <1% 289 $29K
73562 <1% 2,826 $27K
80143 <1% 2,171 $26K
73221 <1% 452 $26K
82565 <1% 1,305 $25K
80179 <1% 2,139 $25K
94060 <1% 940 $25K
72100 <1% 2,370 $23K
62323 <1% 161 $23K
93798 <1% 626 $22K
73030 <1% 2,014 $21K
76770 <1% 500 $21K
85379 <1% 2,504 $20K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 78 $20K
94729 <1% 1,084 $20K
84443 Thyroid stimulating hormone (TSH) <1% 1,660 $20K
81003 <1% 5,849 $20K
87210 <1% 2,130 $19K
87077 <1% 1,669 $19K
93970 <1% 436 $18K
87040 <1% 1,536 $18K
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation <1% 435 $17K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 3,310 $17K
85610 <1% 5,271 $17K
87070 <1% 861 $16K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 877 $16K
70486 <1% 438 $14K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 13,540 $14K
85730 <1% 3,243 $14K
64493 <1% 98 $14K
87186 <1% 1,934 $14K
76642 <1% 371 $14K
95816 <1% 195 $13K
73130 <1% 1,436 $13K
73110 <1% 1,261 $12K
29580 <1% 267 $12K
84703 <1% 1,455 $12K
64494 <1% 103 $12K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 6,117 $11K
94726 <1% 1,061 $10K
71045 Radiologic examination, chest; single view <1% 12,982 $10K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,487 $10K
77063 Screening digital breast tomosynthesis, bilateral <1% 2,039 $10K
74183 <1% 106 $9K
73502 <1% 959 $9K
82805 <1% 232 $9K
81002 <1% 271 $8K
93351 <1% 62 $8K
78815 Positron emission tomography (PET) for limited area imaging <1% 62 $8K
97116 <1% 544 $8K
71271 <1% 255 $8K
85027 <1% 1,595 $7K
87807 <1% 428 $7K
70491 <1% 75 $7K
82550 <1% 1,442 $7K
12001 <1% 95 $7K
99213 Doctor's office visit, returning patient (routine) <1% 125 $7K
86901 <1% 2,545 $6K
P9016 Red blood cells, leukocytes reduced, each unit <1% 15 $5K
87088 <1% 766 $5K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 102 $5K
93880 <1% 174 $5K
73140 <1% 526 $5K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 326 $4K
87075 <1% 577 $4K
90715 <1% 332 $4K
86140 <1% 879 $3K
72040 <1% 302 $3K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 91 $3K
73080 <1% 336 $3K
83036 Hemoglobin; glycosylated (A1C) <1% 377 $3K
93225 <1% 225 $3K
J1756 Injection, iron sucrose, 1 mg <1% 110 $3K
10005 <1% 12 $3K
J0690 Injection, cefazolin sodium, 500 mg <1% 5,308 $3K
64483 <1% 15 $3K
78264 <1% 34 $2K
87205 <1% 780 $2K
74178 <1% 39 $2K
99152 <1% 297 $2K
93308 <1% 12 $2K
72197 <1% 26 $2K
Q3014 Telehealth originating site facility fee <1% 531 $2K
93321 <1% 12 $2K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 14 $2K
76882 <1% 45 $2K
G0297 Low dose ct scan (ldct) for lung cancer screening <1% 57 $2K
J7120 Ringers lactate infusion, up to 1000 cc <1% 14,331 $2K
83615 <1% 313 $2K
73590 <1% 328 $2K
71101 <1% 248 $2K
85652 <1% 754 $1K
80061 Lipid panel <1% 127 $1K
96375 Therapeutic injection; each additional sequential IV push <1% 9,027 $1K
88307 <1% 238 $1K
12011 <1% 25 $1K
36430 <1% 24 $1K
97163 <1% 44 $1K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 5,954 $1K
97802 <1% 58 $1K
95811 <1% 13 $1K
92526 <1% 49 $1K
74019 <1% 101 $1K
77066 Tomosynthesis, mammo <1% 48 $971.78
82150 <1% 174 $929.74
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 82 $855.78
A9609 Fludeoxyglucose f18 up to 15 millicuries <1% 13 $846.75
84439 <1% 126 $792.25
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 13 $743.81
82010 <1% 106 $736.17
86923 <1% 35 $588.06
85014 <1% 180 $563.05
84550 <1% 156 $546.16
20553 <1% 15 $545.80
93325 <1% 26 $509.85
J2785 Injection, regadenoson, 0.1 mg <1% 1,647 $468.80
76937 <1% 128 $468.50
82272 <1% 159 $443.17
76870 <1% 30 $433.55
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 15 $392.68
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 2,098 $357.00
88304 <1% 278 $356.40
97022 <1% 31 $341.35
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 383 $324.73
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 422 $316.14
99203 Doctor's office visit, new patient (routine) <1% 12 $312.80
96376 <1% 2,667 $309.64
Q0243 Injection, casirivimab and imdevimab, 2400 mg <1% 23 $289.09
36000 <1% 887 $283.74
A9585 Injection, gadobutrol, 0.1 ml <1% 3,495 $278.21
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 8,126 $227.98
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,324 $211.06
73564 <1% 27 $208.19
74230 <1% 14 $207.62
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 14,112 $201.36
72070 <1% 66 $192.89
99001 <1% 54 $187.08
J3010 Injection, fentanyl citrate, 0.1 mg <1% 6,295 $179.09
A6222 Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing <1% 286 $158.07
J1170 Injection, hydromorphone, up to 4 mg <1% 6,326 $156.11
74022 <1% 335 $156.06
77065 Tomosynthesis, mammo <1% 12 $148.76
C1769 Guide wire <1% 2,713 $147.42
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 14,405 $134.83
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 2,441 $121.97
J1644 Injection, heparin sodium, per 1000 units <1% 1,969 $121.72
J7030 Infusion, normal saline solution , 1000 cc <1% 20,439 $121.56
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 4,973 $114.57
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 2,090 $114.10
J1030 Injection, methylprednisolone acetate, 40 mg <1% 227 $112.54
83550 <1% 16 $103.83
84132 <1% 39 $101.04
84156 <1% 35 $97.03
73660 <1% 14 $94.56
84100 <1% 33 $94.37
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 7,511 $94.04
73090 <1% 81 $85.80
83540 <1% 16 $76.94
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 474 $76.23
80076 <1% 12 $76.13
82570 <1% 16 $75.33
J2704 Injection, propofol, 10 mg <1% 14,375 $69.92
87147 <1% 12 $59.28
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 1,359 $58.65
80050 General health panel <1% 154 $58.02
Q9957 Injection, perflutren lipid microspheres, per ml <1% 1,103 $56.56
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 11,711 $46.55
36415 Collection of venous blood by venipuncture <1% 5,989 $45.13
72170 <1% 26 $30.28
A6021 Collagen dressing, sterile, size 16 sq. in. or less, each <1% 509 $11.65
A6212 Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing <1% 272 $8.80
C2617 Stent, non-coronary, temporary, without delivery system <1% 30 $6.95
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 1,329 $5.45
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,020 $3.46
J0780 Injection, prochlorperazine, up to 10 mg <1% 894 $1.75
C9113 Injection, pantoprazole sodium, per vial <1% 838 $1.22
J7050 Infusion, normal saline solution, 250 cc 0% 910 $0.00
J1010 Injection, methylprednisolone acetate, 1 mg 0% 230 $0.00
88342 0% 328 $0.00
J2060 Injection, lorazepam, 2 mg 0% 1,287 $0.00
J3480 Injection, potassium chloride, per 2 meq 0% 368 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 0% 1,913 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 0% 638 $0.00
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 55 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 0% 2,602 $0.00
J0360 Injection, hydralazine hcl, up to 20 mg 0% 790 $0.00
J1815 Injection, insulin, per 5 units 0% 1,668 $0.00
J7999 Compounded drug, not otherwise classified 0% 404 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 0% 161 $0.00
J1920 Injection, labetalol hydrochloride, 5 mg 0% 100 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 119 $0.00
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 0% 786 $0.00
J2469 Injection, palonosetron hcl, 25 mcg 0% 458 $0.00
J1790 Injection, droperidol, up to 5 mg 0% 423 $0.00
C1781 Mesh (implantable) 0% 12 $0.00
80320 0% 27 $0.00
A6213 Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing 0% 43 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 0% 28 $0.00
99153 Mod sedat endo service >5yrs 0% 50 $0.00
J0173 Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg 0% 14 $0.00
J3590 Unclassified biologics 0% 27 $0.00
C1726 Catheter, balloon dilatation, non-vascular 0% 13 $0.00
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) 0% 28 $0.00
73552 0% 14 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 89 $0.00
J1940 Injection, furosemide, up to 20 mg 0% 57 $0.00
J1040 Injection, methylprednisolone acetate, 80 mg 0% 12 $0.00
G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals 0% 13 $0.00
C9290 Injection, bupivacaine liposome, 1 mg 0% 14 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 371 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 0% 472 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 368 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 0% 937 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 1,321 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 2,954 $0.00
J1650 Injection, enoxaparin sodium, 10 mg 0% 625 $0.00
A4565 Slings 0% 141 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 0% 1,206 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 451 $0.00
J7510 Prednisolone oral, per 5 mg 0% 116 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 309 $0.00
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 0% 81 $0.00
88302 0% 39 $0.00
C1758 Catheter, ureteral 0% 84 $0.00
J3370 Injection, vancomycin hcl, 500 mg 0% 238 $0.00
A6210 Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing 0% 19 $0.00
A6403 Gauze, non-impregnated, sterile, pad size more than 16 sq. in. less than or equal to 48 sq. in., without adhesive border, each dressing 0% 83 $0.00
C1729 Catheter, drainage 0% 54 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 147 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 81 $0.00
C1776 Joint device (implantable) 0% 12 $0.00
A9541 Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries 0% 17 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 21 $0.00
J0736 Injection, clindamycin phosphate, 300 mg 0% 12 $0.00
Q0244 Injection, casirivimab and imdevimab, 1200 mg 0% 14 $0.00
J0744 Injection, ciprofloxacin for intravenous infusion, 200 mg 0% 34 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRICHARDSON, KARA (VP MANAGED HEEALTH)
Same official

Other billing entities under RICHARDSON, KARA

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.